Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 552 Colorectal Neoplasms 246 Neoplasms 232 Prostatic Neoplasms 221 Carcinoma, Non-Small-Cell Lung 196 Stomach Neoplasms 153 Leukemia, Myeloid, Acute 149 Carcinoma, Hepatocellular 147 Lung Neoplasms 137 Rectal Neoplasms 135 Multiple Myeloma 133 Nasopharyngeal Carcinoma 112 Colonic Neoplasms 106 Neoplasm Metastasis 100 Precursor Cell Lymphoblastic Leukemia-Lymphoma 86 Lymphoma 85 Uterine Cervical Neoplasms 83 Pancreatic Neoplasms 82 Lymphoma, Large B-Cell, Diffuse 79 Ovarian Neoplasms 78 Leukemia 78 Head and Neck Neoplasms 77 Esophageal Neoplasms 74 Lymphoma, Follicular 72 Brain Neoplasms 70 Squamous Cell Carcinoma of Head and Neck 65 Recurrence 64 Leukemia, Lymphocytic, Chronic, B-Cell 59 Lymphoma, Non-Hodgkin 58 Pain 56

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Drug Resistant Epilepsy × Clear all

NCT05534672 2023-08-08

RaRE-TS

Children's Memorial Health Institute, Poland

Phase 3 Recruiting

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡